Myelocytomatosis‐Protein Arginine N‐Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma

Yuhong Luo, Yuqing Gao, Weiwei Liu, Yuan Yang, Jie Jiang, Ying Wang, Wei Tang, Shoumei Yang, Lulu Sun, Jie Cai, Xiaozhen Guo, Shogo Takahashi, Kristopher W. Krausz, Aijuan Qu, Lei Chen, Cen Xie, Frank J. Gonzalez – 24 April 2021

The Future of Quality Improvement for Cirrhosis

Elliot B. Tapper, Neehar D. Parikh – 21 April 2021 – Cirrhosis has a significant and growing impact on public health and patient‐reported outcomes (PROs). The increasing burden of cirrhosis has led to an emphasis on the quality of care with the goal of improving overall outcomes in this high‐risk population. Existing evidence has shown the significant gaps in quality across process measures (eg, hepatocellular carcinoma screening), highlighting the need for consistent measurement and interventions to address the gaps in quality care.

Subscribe to